Stockreport

Bernstein Lifts PT on BioMarin Pharmaceutical (BMRN) to $94 From $90, Here's Why [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) is one of the top gene therapy stocks to buy according to hedge funds . On February 25, Bernstein lifted the price target o [Read more]